UGA Biopharma GmbH
Hennigsdorf, Germany
|
UGA Biopharma, a CRO in cell line development, offers ready-to-use biosimilar expressing cell lines and customized cell line development services for new biological entities (NBEs). Bioprocess optimization, downstream development and analytics are included.
The success is based on the choice of an appropriate host cell line, optimized expression vectors and use of a proprietary, high-performance First CHOice cell culture medium. Chinese Hamster Ovary (CHO) clones are the most commonly used...